Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group

Publications

>

Article

Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group

Publicated to:Bmc Cancer. 21 (1): 230- - 2021-12-01 21(1), DOI: 10.1186/s12885-021-07922-5

Authors: Provencio, M; Terrasa, J; Garrido, P; Campelo, RG; Aparisi, F; Diz, P; Aguiar, D; García-Giron, C; Hidalgo, J; Aguado, C; González, JG; Esteban, E; Gómez-Aldavarí, L; Moran, T; Juan, O; Chara, LE; Marti, JL; Castro, RL; Ortega, AL; Moreno, EM; Coves, J; Peña, AMS; Bosch-Barrera, J; Gastaldo, AS; Núñez, NF; del Barco, E; Cobo, M; Isla, D; Majem, M; Navarro, F; Calvo, V

Affiliations

Badalona Applied Research Group in Oncology - Author

Complejo Asistencial Universitario de Burgos - Author

Complejo Asistencial Universitario de León - Author

Complejo Hospitalario - Author

Complejo Hospitalario de Toledo - Author

Complejo Hospitalario Universitario de Albacete - Author

Complejo Hospitalario Universitario de Santiago - Author

Germans Trias i Pujol Research Institute - Author

Hospital Clinico San Carlos de Madrid - Author

Hospital Clínico Universitario de Salamanca - Author

Hospital Clínico Universitario de Valladolid - Author

Hospital Clínico Universitario Lozano Blesa - Author

Hospital de Gran Canaria Dr. Negrin - Author

Hospital de la Santa Creu i Sant Pau - Author

Hospital General Universitario de Alicante - Author

Hospital General Universitario de Valencia - Author

Hospital Lluis Alcanyis - Author

Hospital Ramón y Cajal - Author

Hospital Universitari Germans Trias i Pujol - Author

Hospital Universitari I Politècnic la Fe - Author

Hospital Universitari Principe de Asturias - Author

Hospital Universitari Son Llàtzer - Author

Hospital Universitario Central de Asturias - Author

Hospital Universitario de Getafe - Author

Hospital Universitario de Guadalajara - Author

Hospital Universitario Lucus Augusti - Author

Hospital Universitario Puerta de Hierro - Author

Hospital Universitario Son Espases - Author

HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO - Author

Institut català d’Oncologia - Author

Institute Catala Oncologia - Author

Instituto de Investigación Biomédica de A Coruña (INIBIC) - Author

Unidad de Gestión Clínica Intercentros de Oncología Médica - Author

Universidad Autónoma de Madrid - Author

Universidade da Coruña - Author

Universitat Autònoma de Barcelona - Author

‎ Badalona Appl Res Grp Oncol, Barcelona, Spain - Author

‎ Complejo Asistencial Univ Leon, Med Oncol Dept Leon, Madrid, Spain - Author

‎ Complejo Hosp Jaen, Med Oncol Dept, Jaen, Spain - Author

‎ Complejo Hosp Univ Albacete, Med Oncol Dept, Albacete, Spain - Author

‎ Dr Josep Trueta Univ Hosp, Dept Oncol, Catalan Inst Oncol, Girona, Spain - Author

‎ Fundacio Germans Trias & Pujol, Barcelona, Spain - Author

‎ Hosp Badalona Germans Trias & Pujol, Barcelona, Spain - Author

‎ Hosp Clin San Carlos, Med Oncol Dept, Madrid, Spain - Author

‎ Hosp Clin Univ Santiago, Med Oncol Dept Santiago Compostela, Madrid, Spain - Author

‎ Hosp Clin Univ Valladolid, Med Oncol Dept, Valladolid, Spain - Author

‎ Hosp Gen Univ Alicante, Med Oncol Dept, Alicante, Spain - Author

‎ Hosp Gen Univ Valencia, Med Oncol Dept Valencia, Madrid, Spain - Author

‎ Hosp Lluis Alcanyis, Med Oncol Dept, Valencia, Spain - Author

‎ Hosp Santa Creu & Sant Pau, Med Oncol Dept, Barcelona, Spain - Author

‎ Hosp Son Llatzer, Med Oncol Dept, Palma De Mallorca, Spain - Author

‎ Hosp Univ & Politecn La Fe, Med Oncol Dept, Valencia, Spain - Author

‎ Hosp Univ A Coruna, Med Oncol Dept, La Coruna, Spain - Author

‎ Hosp Univ Burgos, Med Oncol Dept, Burgos, Spain - Author

‎ Hosp Univ Cent Asturias, Med Oncol Dept, Oviedo, Spain - Author

‎ Hosp Univ Getafe, Med Oncol Dept, Madrid, Spain - Author

‎ Hosp Univ Gran Canaria Dr Negrin, Med Oncol Dept, Las Palmas De Gc, Spain - Author

‎ Hosp Univ Guadalajara, Med Oncol Dept, Guadalajara, Spain - Author

‎ Hosp Univ Lozano Blesa, Med Oncol Dept, Zaragoza, Aragon, Spain - Author

‎ Hosp Univ Lucus Augusti, Med Oncol Dept, Lugo, Spain - Author

‎ Hosp Univ Principe Asturias, Med Oncol Dept, Alcala De Henares, Spain - Author

‎ Hosp Univ Puerta Hierro, Hlth Res Inst, Madrid, Spain - Author

‎ Hosp Univ Puerta Hierro, Med Oncol Dept, Madrid, Spain - Author

‎ Hosp Univ Reg & Virgen Victoria, Unidad Gest Clin Intercentros Oncol Med, IBIMA, Malaga, Spain - Author

‎ Hosp Univ Salamanca, Med Oncol Dept, Salamanca, Spain - Author

‎ Hosp Univ Son Espases, Med Oncol Dept, Palma De Mallorca, Spain - Author

‎ Hosp Univ Virgen Rocio, Med Oncol Dept, Seville, Spain - Author

‎ Hosp Virgen Salud, Med Oncol Dept, Toledo, Spain - Author

‎ Inst Catala Oncol Badalona, Med Oncol Dept, Barcelona, Spain - Author

‎ Inst Invest Biomed A Coruna INIBIC, La Coruna, Spain - Author

‎ IRYCIS Hosp Univ Ramon y Cajal, Med Oncol Dept, Madrid, Spain - Author

‎ Univ Autonoma Barcelona, Dept Med, Barcelona, Spain - Author

‎ Univ Autonoma Madrid, Madrid, Spain - Author

Abstract

Keywords

egfr-activating mutationsnon-small cell lung cancerosimertinibreal-world datasecond linet790m egfr mutationEgfr-activating mutationsNon-small cell lung cancerOsimertinibReal-world dataSecond lineT790m egfr mutation

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Bmc Cancer due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2021, it was in position 109/245, thus managing to position itself as a Q2 (Segundo Cuartil), in the category Oncology. Notably, the journal is positioned en el Cuartil Q2 para la agencia Scopus (SJR) en la categoría Oncology.

From a relative perspective, and based on the normalized impact indicator calculated from the Field Citation Ratio (FCR) of the Dimensions source, it yields a value of: 3.85, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: Dimensions May 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-05-02, the following number of citations:

WoS: 10
Scopus: 11
OpenCitations: 11

Indexed in

License and use

Citations

Altmetrics

Analysis of institutional authors

Share